Dr. Kimberly L. Blackwell on a Promising HER2 Breast Cancer Treatment ByKimberly L. Blackwell, MDOctober 27th 2015Kimberly L. Blackwell, MD, professor of Medicine, assistant professor of Radiation Oncology, Duke Cancer Institute, discusses upcoming trials for the HER2-antibody margetuximab.